UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000031621 |
|---|---|
| Receipt number | R000036095 |
| Scientific Title | Retrospective analysis of randomized phase II trial (WJOG6210G) of FOLFIRI with either panitumumab or bevacizumab as second-line treatment in patients with KRAS wild metastatic colorectal cancer refractory to oxaliplatin and bevacizumab to evaluate the association of survival time and treatment efficacy (early tumor shrinkage, depth of response and best overall response) at each arm |
| Date of disclosure of the study information | 2018/03/07 |
| Last modified on | 2021/09/08 11:00:04 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2018/03/07 11:13:30 | ||
| 2 | Update | 2018/04/12 10:29:38 | Recruitment status Anticipated trial start date |
|
| 3 | Update | 2021/09/08 11:00:04 | Recruitment status Date of IRB Last follow-up date |
